login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CTI BIOPHARMA CORP (CTIC) Stock News
USA
- NASDAQ:CTIC -
US12648L6011
-
Common Stock
9.09
USD
0 (0%)
Last: 6/23/2023, 8:00:00 PM
9.09
USD
0 (0%)
After Hours:
6/23/2023, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CTIC Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Investor's Business Daily
- Mentions:
INCY
GSK
Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival
2 years ago - By: Swedish Orphan Biovitrum AB
Sobi completes acquisition of CTI BioPharma Corp.
2 years ago - By: Swedish Orphan Biovitrum AB
Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.
2 years ago - By: Kahn Swick & Foti, LLC
CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC
2 years ago - By: Benzinga
The Latest Analyst Ratings for CTI BioPharma
2 years ago - By: InvestorPlace
- Mentions:
BBLN
UFAB
Why Is Babylon (BBLN) Stock Down 57% Today?
2 years ago - By: InvestorPlace
- Mentions:
UFAB
Why Is CTI BioPharma (CTIC) Stock Up 85% Today?
2 years ago - By: CTI BioPharma Corp.
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders
2 years ago - By: Benzinga
- Mentions:
ACAD
MMSI
CERE
VYGR
Top 5 Health Care Stocks That Should Keep You Up At Night
2 years ago - By: CTI BioPharma
Sobi to Acquire CTI BioPharma
2 years ago - By: CTI BioPharma Corp.
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 years ago - By: Kahn Swick & Foti, LLC
CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC
2 years ago - By: The Motley Fool
Why Shares of CTI BioPharma Are Soaring Wednesday
2 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether CTI BioPharma Corp. has obtained a Fair Price in its transaction with Sobi
2 years ago - By: InvestorPlace
- Mentions:
SYNH
ICU
BBLN
SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up Today
2 years ago - By: InvestorPlace
- Mentions:
ICU
BBLN
UFAB
Why Is SeaStar Medical (ICU) Stock Down 32% Today?
2 years ago - By: Halper Sadeh LLC
CTIC STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of CTI BioPharma Corp. Is Fair to Shareholders
2 years ago - By: InvestorPlace
- Mentions:
UFAB
ADXN
UPST
DRTT
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
2 years ago - By: Seeking Alpha
Swedish Orphan Biovitrum Ab to acquire CTI BioPharma for $9.10 per share (NASDAQ:CTIC)
2 years ago - By: CTI BioPharma Corp.
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Please enable JavaScript to continue using this application.